Overview: Centene’s Strong Q1 2026 Performance
Centene Corporation delivered a standout first quarter in 2026, posting $1.5 billion in net earnings. The company released its April 28 earnings report, revealing adjusted diluted earnings per share of $3.37. That figure beat analyst expectations by approximately $0.50 — a significant outperformance by any measure.
Moreover, Centene raised its full-year 2026 guidance on the back of these results. The insurer increased its premium and service revenues forecast by $1 billion, setting the new range between $171 billion and $175 billion. Additionally, the company lifted its full-year adjusted diluted EPS guidance floor to greater than $3.40, up from its prior outlook.
Despite these strong financial numbers, the quarter was not without challenges. Centene’s ACA marketplace membership fell sharply, creating headwinds in its commercial segment.
Revenue Growth and Raised Guidance
Total Revenues Rise Year Over Year
Total revenues for Q1 2026 reached $49.9 billion, compared to $46.6 billion in the same quarter of 2025. That represents solid year-over-year growth across Centene’s diversified portfolio.
Guidance Upgrades Signal Confidence
Centene’s decision to raise guidance reflects confidence in its underlying business performance. The company increased its full-year premium and service revenue range by $1 billion, pointing to stronger-than-expected performance across its government-sponsored programs. Furthermore, the revised EPS floor signals that management expects this outperformance to carry through the rest of 2026.
ACA Marketplace Membership Declines Sharply
A Drop of 2 Million Members
One of the most notable developments this quarter was the sharp drop in ACA marketplace enrollment. Centene’s ACA membership fell to 3.6 million, down from 5.6 million in Q1 2025. As a result, the company lost approximately 2 million marketplace members year over year.
Impact on Commercial Medical Loss Ratio
This decline in ACA membership directly affected Centene’s commercial segment performance. The company noted that the membership drop weighed on its consolidated member mix. Consequently, the commercial medical loss ratio came in at 75.3%. The ACA membership loss therefore remains a key challenge for Centene as it navigates the marketplace in 2026.
Medical Loss Ratios Across All Segments
Overall MLR Shows Modest Improvement
Centene’s overall medical loss ratio for Q1 2026 was 87.3%, a slight improvement from 87.5% in the same period last year. While the improvement is modest, it reflects disciplined cost management across the business.
Medicaid MLR Improves 50 Basis Points
The Medicaid segment saw a meaningful improvement. Centene’s Medicaid MLR improved by 50 basis points year over year, falling to 93.1%. The company attributed this progress to rate and revenue increases, as well as continued focus on managing medical costs effectively.
Medicare MLR Outperforms Expectations
Medicare performance was equally encouraging. The Medicare MLR improved from 86.3% to 84.9% year over year. Centene attributed this gain to outperformance in both its Medicare Advantage plan and its prescription drug plan (PDP) business. Together, these improvements point to stronger operational execution in the Medicare segment.
Medicaid and Medicare Membership Trends
Total Membership Stands at 26.3 Million
At the close of Q1 2026, Centene served approximately 26.3 million total members across all segments. However, total membership declined compared to earlier periods, largely driven by ACA marketplace and Medicaid enrollment changes.
Medicaid Membership Contracts
Medicaid membership stood at 12.4 million at the end of Q1 2026, down from 13 million in Q1 2025. This decline reflects ongoing Medicaid redetermination pressures that continue to affect payers across the industry.
Medicare PDP Membership Grows
In contrast, Medicare PDP membership saw notable growth. Enrollment expanded to 8.8 million from 7.9 million year over year. Meanwhile, total Medicare membership remained at approximately 1 million. The PDP growth offers a bright spot within a quarter otherwise marked by commercial and Medicaid enrollment declines.
What This Means for Centene’s Strategy
Centene’s Q1 2026 results present a mixed but ultimately strong financial picture. The company beat earnings expectations and raised full-year guidance — both positive signals for investors. At the same time, the 2-million-member drop in ACA marketplace enrollment highlights the ongoing volatility in the individual insurance market.
Going forward, Centene’s strategy will likely focus on offsetting ACA membership losses through continued strength in Medicare PDP, improved Medicaid cost management, and revenue growth across its government-sponsored programs. The company’s ability to raise guidance despite commercial headwinds suggests it has confidence in those offsetting factors.
Overall, Centene enters the rest of 2026 in a position of financial strength, even as it manages the structural shifts reshaping the health insurance marketplace.
